Media
Press release
Vul een zoekterm in.
05/04/12
STALLERGENES HAS IDENTIFIED TWO CANDIDATE BIOMARKERS OF EARLY EFFICACY OF ALLERGEN IMMUNOTHERAPY
--
21/03/12
STALLERGENES CONTINUES ITS INTERNATIONAL EXPANSION WITH THE SUCCESSFULL REGISTRATION IN CANADA
--